Yves Renaudineau
Renaudineau, Yves, 1969-....
VIAF ID: 198794149 (Personal)
Permalink: http://viaf.org/viaf/198794149
Preferred Forms
-
100 1 _ ‡a Renaudineau, Yves ‡d 1969-...
-
100 1 _ ‡a Renaudineau, Yves, ‡d 1969-....
-
100 0 _ ‡a Yves Renaudineau
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
B lymphocytes apoptosis resistance in chronic lymphocytic leukemia : implication of a neurotrophin, BDNF, the neurotensin receptor NTSR2, and Nurse-Like Cells. |
![]() |
Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica |
![]() |
Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration |
![]() |
Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome |
![]() |
Diagnostic and pathogenic implications of the heterogeneity of antiendothelial cell antibodies. |
![]() |
The Differential Diagnosis of Dry Eyes, Dry Mouth, and Parotidomegaly: A Comprehensive Review |
![]() |
DNA methylation and B-cell autoreactivity |
![]() |
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1 |
![]() |
Effects of anti-endothelial cell antibodies in leprosy and malaria |
![]() |
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study |
![]() |
Endothelium, a target for immune-mediated assault in connective tissue disease |
![]() |
Epigenetics in leukemia |
![]() |
Epigénétique dans les leucémies. |
![]() |
Etude de la signalisation calcique du lymphocyte B en pathologie |
![]() |
Étude des effets de l'alpha-énolase sur les cellules mononucléées du sang périphérique de sujets sains et de patients atteints de polyarthrite rhumatoïde, et dans le modèle murin d'arthrite induite au collagène |
![]() |
The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome |
![]() |
Follicular helper T cells involvement in the physiopathogenesis of chronic lymphocytic leukemia. |
![]() |
Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis |
![]() |
How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses |
![]() |
Human endogenous retrovirus group E and its involvement in diseases |
![]() |
Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy. |
![]() |
IgG subclasses of human autoantibodies |
![]() |
Immunophenotyping As a New Tool for Classification and Monitoring of Systemic Autoimmune Diseases |
![]() |
Implication des lymphocytes B et de BAFF dans l'apoptose des cellules épithéliales des glandes salivaires au cours du syndrome de Gougerot-Sjögren |
![]() |
Importance of IgG glycosylation in rheumatoid arthritis. |
![]() |
Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20) |
![]() |
In seroconverted rheumatoid arthritis patients a multi-reactive anti-herpes IgM profile is associated with disease activity |
![]() |
Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade |
![]() |
[Influence of epigenetic in Sjögren's syndrome]. |
![]() |
The Innate Part of the Adaptive Immune System |
![]() |
Interest of the CD5 |
![]() |
Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity |
![]() |
Isolated Cardiac Richter Syndrome: a Case Report |
![]() |
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes |
![]() |
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. |
![]() |
Maladies auto-immunes et marqueurs sérologiques : l’exemple des anticorps anti-phospholipides et des chaînes légères libres |
![]() |
Mécanismes épigénétiques et influence du micro-environnement tumoral |
![]() |
Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis |
![]() |
Methylome alterations during Sjögren’s syndrome. |
![]() |
MicroRNAs and multiple sclerosis: from physiopathology toward therapy |
![]() |
Molecular Dynamics Simulations of Membrane-Bound STIM1 to Investigate Conformational Changes during STIM1 Activation upon Calcium Release. |
![]() |
Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects |
![]() |
The new B-cell-specific exon 1B of the CD5 mRNA favors autoimmunity by preventing the membrane expression of CD5. |
![]() |
New ELISA for B cell-activating factor |
![]() |
News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination |
![]() |
No. |
![]() |
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion |
![]() |
Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT |
![]() |
The paradox of CD5-expressing B cells in systemic lupus erythematosus |
![]() |
Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases |
![]() |
Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei |
![]() |
Pierre Youinou: when intuition and determination meet autoimmunity. |
![]() |
Prevalence of antibodies to hepatitis C among recently treated leprosy patients in Senegal parallels those in normal populations |
![]() |
Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells |
![]() |
Rapid and complete response to idelalisib in a case of Richter syndrome |
![]() |
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases |
![]() |
Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab). |
![]() |
Re-emergence of yellow fever in Senegal in 1995. |
![]() |
Ré-évaluation de l'apport de l'immunofluorescence directe (recherche de lupus band test) seul et combiné dans le diagnostic du lupus et de sa forme systémique |
![]() |
Recent progress in the understanding of B-cell functions in autoimmunity |
![]() |
Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation |
![]() |
Régulation du gène CD5 dans les lymphocytes B humains |
![]() ![]() |
The regulatory capacity of B cells directs the aggressiveness of CLL |
![]() |
Renal involvement in Wegener's granulomatosis. |
![]() |
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy |
![]() |
The revolution of epigenetics in the field of autoimmunity |
![]() |
Rheumatoid factor on a daily basis |
![]() |
Rôle des lymphocytes T CD4+ folliculaires dans la physiopathologie de la leucémie lymphoïde chronique |
![]() |
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells |
![]() |
Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren's syndrome |
![]() |
Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden |
![]() |
Soluble Fcgamma receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival |
![]() |
STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia |
![]() |
Study of calcium entries deregulation in chronic lymphocytic leukemia B-cells : evidence for a new therapeutic target. |
![]() ![]() |
Toll-Like Receptors, Infections, and Rheumatoid Arthritis |
![]() |
Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysis. |
![]() |
Virus de l'hépatite C : faible prévalence et sérotype 2 en Afrique de l'Ouest (étude menée à l'Institut Pasteur de Dakar en 1995) |
![]() |